Cargando…

Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential

Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to reduce pain and inflammation. However, their effect on bone metabolisms is not well known, and results in the literature are contradictory. The present study focusses on the effect of dexketoprofen, ketorolac, metamizole, and acety...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luna-Bertos, E., Ramos-Torrecillas, J., García-Martínez, O., Guildford, A., Santin, M., Ruiz, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793504/
https://www.ncbi.nlm.nih.gov/pubmed/24170983
http://dx.doi.org/10.1155/2013/809891
_version_ 1782477827846701056
author De Luna-Bertos, E.
Ramos-Torrecillas, J.
García-Martínez, O.
Guildford, A.
Santin, M.
Ruiz, C.
author_facet De Luna-Bertos, E.
Ramos-Torrecillas, J.
García-Martínez, O.
Guildford, A.
Santin, M.
Ruiz, C.
author_sort De Luna-Bertos, E.
collection PubMed
description Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to reduce pain and inflammation. However, their effect on bone metabolisms is not well known, and results in the literature are contradictory. The present study focusses on the effect of dexketoprofen, ketorolac, metamizole, and acetylsalicylic acid, at therapeutic doses, on different biochemical and phenotypic pathways in human osteoblast-like cells. Osteoblasts (MG-63 cell line) were incubated in culture medium with 1–10 μM of dexketoprofen, ketorolac, metamizole, and acetylsalicylic acid. Flow cytometry was used to study antigenic profile and phagocytic activity. The osteoblastic differentiation was evaluated by mineralization and synthesis of collagen fibers by microscopy and alkaline phosphatase activity (ALP) by spectrophotometric assay. Short-term treatment with therapeutic doses of NSAIDs modulated differentiation, antigenic profile, and phagocyte activity of osteoblast-like cells. The treatment reduced ALP synthesis and matrix mineralization. However, nonsignificant differences were observed on collagen syntheses after treatments. The percentage of CD54 expression was increased with all treatments. CD80, CD86, and HLA-DR showed a decreased expression, which depended on NSAID and the dose applied. The treatments also decreased phagocyte activity in this cellular population. The results of this paper provide evidences that NSAIDs inhibit the osteoblast differentiation process thus reducing their ability to produce new bone mineralized extracellular matrix.
format Online
Article
Text
id pubmed-3793504
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37935042013-10-29 Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential De Luna-Bertos, E. Ramos-Torrecillas, J. García-Martínez, O. Guildford, A. Santin, M. Ruiz, C. ScientificWorldJournal Research Article Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to reduce pain and inflammation. However, their effect on bone metabolisms is not well known, and results in the literature are contradictory. The present study focusses on the effect of dexketoprofen, ketorolac, metamizole, and acetylsalicylic acid, at therapeutic doses, on different biochemical and phenotypic pathways in human osteoblast-like cells. Osteoblasts (MG-63 cell line) were incubated in culture medium with 1–10 μM of dexketoprofen, ketorolac, metamizole, and acetylsalicylic acid. Flow cytometry was used to study antigenic profile and phagocytic activity. The osteoblastic differentiation was evaluated by mineralization and synthesis of collagen fibers by microscopy and alkaline phosphatase activity (ALP) by spectrophotometric assay. Short-term treatment with therapeutic doses of NSAIDs modulated differentiation, antigenic profile, and phagocyte activity of osteoblast-like cells. The treatment reduced ALP synthesis and matrix mineralization. However, nonsignificant differences were observed on collagen syntheses after treatments. The percentage of CD54 expression was increased with all treatments. CD80, CD86, and HLA-DR showed a decreased expression, which depended on NSAID and the dose applied. The treatments also decreased phagocyte activity in this cellular population. The results of this paper provide evidences that NSAIDs inhibit the osteoblast differentiation process thus reducing their ability to produce new bone mineralized extracellular matrix. Hindawi Publishing Corporation 2013-09-19 /pmc/articles/PMC3793504/ /pubmed/24170983 http://dx.doi.org/10.1155/2013/809891 Text en Copyright © 2013 E. De Luna-Bertos et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
De Luna-Bertos, E.
Ramos-Torrecillas, J.
García-Martínez, O.
Guildford, A.
Santin, M.
Ruiz, C.
Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title_full Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title_fullStr Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title_full_unstemmed Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title_short Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential
title_sort therapeutic doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma mg-63 osteoblast-like cells maturation, viability, and biomineralization potential
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793504/
https://www.ncbi.nlm.nih.gov/pubmed/24170983
http://dx.doi.org/10.1155/2013/809891
work_keys_str_mv AT delunabertose therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential
AT ramostorrecillasj therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential
AT garciamartinezo therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential
AT guildforda therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential
AT santinm therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential
AT ruizc therapeuticdosesofnonsteroidalantiinflammatorydrugsinhibitosteosarcomamg63osteoblastlikecellsmaturationviabilityandbiomineralizationpotential